论文信息 - A randomized phase II trial of PEXG (cisplatin, epirubicin, capecitabine, gemcitabine) or PDXG (docetaxel) regimen in advanced pancreatic adenocarcinoma - 字舞流文

A randomized phase II trial of PEXG (cisplatin, epirubicin, capecitabine, gemcitabine) or PDXG (docetaxel) regimen in advanced pancreatic adenocarcinoma

M. Reni | P. Passoni | A. Zerbi | P. Arcidiacono | A. Rognone | G. Balzano | V. Carlo | R. Nicoletti | E. Mazza | S. Cereda